1 Solem CA, "Venous thromboembolism in inflammatory bowel disease" 99 : 97-101, 2004
2 Grainge MJ, "Venous thromboembolism during active disease and remission in inflammatory bowel disease : a cohort study" 375 : 657-663, 2010
3 Fumery M, "Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases : a meta-analysis of observational studies" 8 : 469-479, 2014
4 Bernstein CN, "The prevalence of extraintestinal diseases in inflammatory bowel disease : a population-based study" 96 : 1116-1122, 2001
5 Hedin CR, "The pathogenesis of extraintestinal manifestations : implications for IBD research, diagnosis, and therapy" 13 : 541-554, 2019
6 Bernstein CN, "The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease : a population-based cohort study" 85 : 430-434, 2001
7 Harbord M, "The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease" 10 : 239-254, 2016
8 Hayashi H, "Successful treatment with infliximab for refractory pyoderma gangrenosum associated with inflammatory bowel disease" 39 : 576-578, 2012
9 Nguyen GC, "Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients" 103 : 2272-2280, 2008
10 Polcz M, "Pyoderma gangrenosum in inflammatory bowel disease : the experience at Mater Health Services’ Adult Hospital 1998-2009" 5 : 148-151, 2011
1 Solem CA, "Venous thromboembolism in inflammatory bowel disease" 99 : 97-101, 2004
2 Grainge MJ, "Venous thromboembolism during active disease and remission in inflammatory bowel disease : a cohort study" 375 : 657-663, 2010
3 Fumery M, "Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases : a meta-analysis of observational studies" 8 : 469-479, 2014
4 Bernstein CN, "The prevalence of extraintestinal diseases in inflammatory bowel disease : a population-based study" 96 : 1116-1122, 2001
5 Hedin CR, "The pathogenesis of extraintestinal manifestations : implications for IBD research, diagnosis, and therapy" 13 : 541-554, 2019
6 Bernstein CN, "The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease : a population-based cohort study" 85 : 430-434, 2001
7 Harbord M, "The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease" 10 : 239-254, 2016
8 Hayashi H, "Successful treatment with infliximab for refractory pyoderma gangrenosum associated with inflammatory bowel disease" 39 : 576-578, 2012
9 Nguyen GC, "Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients" 103 : 2272-2280, 2008
10 Polcz M, "Pyoderma gangrenosum in inflammatory bowel disease : the experience at Mater Health Services’ Adult Hospital 1998-2009" 5 : 148-151, 2011
11 Aghazadeh R, "Inflammatory bowel disease in Iran : a review of 457 cases" 20 : 1691-1695, 2005
12 Zezos P, "Inflammatory bowel disease and thromboembolism" 20 : 13863-13878, 2014
13 Vavricka SR, "Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort" 106 : 110-119, 2011
14 Vavricka SR, "Extraintestinal manifestations of inflammatory bowel disease" 21 : 1982-1992, 2015
15 Jose FA, "Extraintestinal manifestations of inflammatory bowel disease" 46 : 124-133, 2008
16 Greuter T, "Extraintestinal manifestations in inflammatory bowel disease : epidemiology, genetics, and pathogenesis" 13 : 307-317, 2019
17 Monsen U, "Extracolonic diagnoses in ulcerative colitis : an epidemiological study" 85 : 711-716, 1990
18 Lebwohl M, "Cutaneous manifestations of inflammatory bowel disease" 4 : 142-148, 1998
19 Papay P, "Clinical presentation of venous thromboembolism in inflammatory bowel disease" 7 : 723-729, 2013
20 K Arivarasan ; Vaishali Bhardwaj ; Sukrit Sud ; Sanjeev Sachdeva ; Amarender Singh Puri, "Biologics for the treatment of pyoderma gangrenosum in ulcerative colitis" 대한장연구학회 14 (14): 365-368, 2016